Evidence map›Paper›PMID 32975184›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2020

Prevention of human rabies: a challenge for the European Union and the European Economic Area.

Céline M Gossner, Alexandra Mailles, Inma Aznar, Elina Dimina, Juan E Echevarría, Siri Laura Feruglio, Heidi Lange, Francesco Paolo Maraglino, Patrizia Parodi, Jurijs Perevoscikovs and 2 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. The European Union One Health 2020 Zoonoses Report.EFSA journal. European Food Safety Authority · 2021
    Article
  12. Article
  13. Review
  14. New global targets for NTDs in the WHO roadmap 2021-2030.PLoS neglected tropical diseases · 2021
    Article
  15. Article
  16. Tackling the Threat of Rabies Reintroduction in Europe.Frontiers in veterinary science · 2020
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Céline M GossnerEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Alexandra MaillesSanté publique France, Saint Maurice, France.
Inma AznarEuropean Food Safety Authority (EFSA), Parma, Italy.
Elina DiminaCentre for Disease Prevention and Control of Latvia, Riga, Latvia.
Juan E EchevarríaCentro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Siri Laura FeruglioNorwegian Institute of Public Health, Oslo, Norway.
Heidi LangeNorwegian Institute of Public Health, Oslo, Norway.
Francesco Paolo MaraglinoMinistry of Health, Rome, Italy.
Patrizia ParodiMinistry of Health, Rome, Italy.
Jurijs PerevoscikovsCentre for Disease Prevention and Control of Latvia, Riga, Latvia.
Yves Van der StedeEuropean Food Safety Authority (EFSA), Parma, Italy.
Tamás BakonyiEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rabies is enzootic in over one hundred countries worldwide. In the European Union/European Economic Area (EU/EEA), the vast majority of human rabies cases are travellers bitten by dogs in rabies-enzootic countries, mostly in Asia and Africa. Thus, EU/EEA travellers visiting rabies enzootic countries should be aware of the risk of being infected with the rabies virus when having physical contact with mammals. They should consider pre-exposure vaccination following criteria recommended by the World Health Organization and if unvaccinated, immediately seek medical attention in case of bites or scratches from mammals. As the majority of the EU/EEA countries are free from rabies in mammals, elimination of the disease (no enzootic circulation of the virus and low number of imported cases) has been achieved by 2020. However, illegal import of potentially infected animals, mainly dogs, poses a risk to public health and might threaten the elimination goal. Additionally, newly recognised bat lyssaviruses represent a potential emerging threat as the rabies vaccine may not confer protective immunity. To support preparedness activities in EU/EEA countries, guidance for the assessment and the management of the public health risk related to rabies but also other lyssaviruses, should be developed.

Indexed as

LyssavirusTravelZoonosesAnimalsDog DiseasesDogsEuropeEuropean UnionHumansRabiesRabies VaccinesRhabdoviridae InfectionsRisk AssessmentRabies Vaccinesbatsdoglyssavirusesrabiestravelvaccination

Identifiers

PMID32975184
PMCPMC7533618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.